Paydirt
DJ
Insider

Daniel Janney

Director

Daniel Janney (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Krystal Biotech, Inc. (KRYS). The largest single filing was $16.0M of KRYS (59,729 sh across 18 lots, as filed), executed Feb 24.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$19.3M
shares × price, as filed
Last traded
Feb 27
Filed Mar 3

Median ADV $140.4M across their filed names

Open performance
Volume by month
$16.0M$8.0M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2026 · sells $16.0MMar 2026 · sells $3.3M
Buys $0 Sells $19.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
KRYS Krystal Biotech, Inc. KRYS · 0 buys · 2 sells 2 filings
Recent filings
KRYSSALE Krystal Biotech, Inc. View filing → $3.3M
11,803 sh across 2 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET
KRYSSALE Krystal Biotech, Inc. View filing → $16.0M
59,729 sh across 18 lots
Exec Feb 24
Filed Feb 26 · 5:30 PM ET